Alexion Pharmaceuticals Inc., of New Haven, Conn., reported 2015 revenues of $2.604 billion, representing 21 percent growth over 2014 revenues of $2.146 billion, excluding the impact of $88 million in 2014 for reimbursement of shipments in prior years.